Pharmafile Logo
Pharmafocus logo
Advanced Search

stevenage

Showing 5 posts of 5 posts found.

gsk_ulverston_plant_impression

GSK to make redundancies at plant in Stevenage

April 17, 2019
Research and Development GSK, GlaxoSmithKline, R&D, redundancies, stevenage

GlaxoSmithKline are set to make redundancies at their site in Stevenage. The move comes as the firm takes “a new …

News
sanofi_hq__boetie_hall

Sanofi reinforces collaboration with Stevenage Bioscience Catalyst with partnering office

April 13, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Sanofi, Stevenage Bioscience Catalyst, academia, industry, partnership, pharma, stevenage

Sanofi has reinforced its collaboration with Stevenage Bioscience Catalyst with the opening of a new partnering office. This office will …

News
Catapult cell therapy

Construction for new £55m cell and gene manufacturing centre in Stevenage begins

November 24, 2015
Manufacturing and Production Catapult, Cell Therapy Catapult, Hertfordshire, gene therapy, manufacturing, stevenage

The Government-backed Cell Therapy Catapult has begun the construction for its cell and gene therapy manufacturing centre.   The construction …

News
Stevenage Bioscience Catalyst campus image

Cell Therapy Catapult to build £55 million bioscience campus

December 17, 2014
Research and Development, Sales and Marketing Cell Therapy Catapult, UK, bioscience, research, stevenage

UK firm The Cell Therapy Catapult has chosen to build a £55 million state-of-the-art cell therapy manufacturing centre in Stevenage. …

News
Actavis image

Actavis to axe 200 jobs

December 4, 2014
Medical Communications, Sales and Marketing Actavis, Allergan, Forest, GSK, Warner Chilcott, corona, stevenage

Actavis is set to cut 200 jobs in the US just weeks after buying Allergan for $66 billion. The lay-offs …

News

Latest content

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024

AstraZeneca shares positive interim results from phase 3 lymphoma trial

May 3, 2024

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024